Jerntorp P, Ohlin H, Sundkvist G, Almér L O
Diabetes Res. 1986 Sep;3(7):369-72.
Aldehyde dehydrogenase (ALDH) activity is increased in Type 2 diabetics with macrovascular disease, and is a critical factor determining the chlorpropamide-alcohol flush (CPAF), a phenomenon possibly related to diabetic complications. To evaluate the possible effects of chlorpropamide (CP) on ALDH activity we studied 8 Type 1 and 20 Type 2 diabetics. Blood acetaldehyde concentration after intake of CP and alcohol was higher in patients with CPAF than in those without CPAF (p less than 0.005), and in those with low basal erythrocyte ALDH activity than in those with high basal enzyme activity (p less than 0.05). Administration of CP reduced ALDH activity in 20 of 26 patients (p less than 0.05). Alcohol intake was observed to have an additional inhibitory effect on ALDH activity. Accordingly, a combination of CP and alcohol decreases the activity of erythrocyte ALDH which might explain the CPAF phenomenon. Absent correlation between CP level and reduction of ALDH activity indicates a major role for alcohol in CPAF. A therapeutic dose of CP or a small amount of alcohol might be used when a reduction of ALDH activity is considered.
醛脱氢酶(ALDH)活性在患有大血管疾病的2型糖尿病患者中升高,并且是决定氯磺丙脲-酒精潮红(CPAF)的关键因素,CPAF这一现象可能与糖尿病并发症相关。为了评估氯磺丙脲(CP)对ALDH活性的可能影响,我们研究了8例1型糖尿病患者和20例2型糖尿病患者。摄入CP和酒精后,出现CPAF的患者血液乙醛浓度高于未出现CPAF的患者(p<0.005),基础红细胞ALDH活性低的患者高于基础酶活性高的患者(p<0.05)。给予CP后,26例患者中有20例ALDH活性降低(p<0.05)。观察到饮酒对ALDH活性有额外的抑制作用。因此,CP和酒精联合使用会降低红细胞ALDH活性,这可能解释了CPAF现象。CP水平与ALDH活性降低之间缺乏相关性表明酒精在CPAF中起主要作用。当考虑降低ALDH活性时,可使用治疗剂量的CP或少量酒精。